Jump Financial LLC Purchases Shares of 35,472 Myomo, Inc. (NYSEAMERICAN:MYO)

Jump Financial LLC acquired a new stake in shares of Myomo, Inc. (NYSEAMERICAN:MYO) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 35,472 shares of the company’s stock, valued at approximately $228,000.

Several other institutional investors have also recently made changes to their positions in the stock. Barclays PLC acquired a new stake in shares of Myomo in the 3rd quarter worth about $36,000. Jane Street Group LLC acquired a new stake in shares of Myomo in the 3rd quarter worth about $65,000. Russell Investments Group Ltd. acquired a new stake in shares of Myomo in the 4th quarter worth about $229,000. AIGH Capital Management LLC raised its holdings in shares of Myomo by 21.7% in the 4th quarter. AIGH Capital Management LLC now owns 3,381,567 shares of the company’s stock worth $21,777,000 after acquiring an additional 602,719 shares during the last quarter. Finally, Perkins Capital Management Inc. acquired a new stake in shares of Myomo in the 4th quarter worth about $483,000. Institutional investors and hedge funds own 44.99% of the company’s stock.

Myomo Stock Performance

Shares of MYO stock opened at $4.84 on Monday. Myomo, Inc. has a 12-month low of $2.76 and a 12-month high of $7.17. The business’s 50 day moving average is $4.86. The stock has a market cap of $146.41 million, a price-to-earnings ratio of -21.04 and a beta of 1.68.

Insiders Place Their Bets

In other news, Director Thomas F. Kirk bought 7,400 shares of the stock in a transaction on Thursday, March 13th. The shares were purchased at an average cost of $5.00 per share, for a total transaction of $37,000.00. Following the completion of the purchase, the director now directly owns 255,933 shares in the company, valued at $1,279,665. This represents a 2.98 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Micah Mitchell sold 48,000 shares of the business’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $5.16, for a total value of $247,680.00. Following the completion of the sale, the insider now owns 140,572 shares in the company, valued at approximately $725,351.52. The trade was a 25.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.54% of the company’s stock.

Wall Street Analyst Weigh In

MYO has been the topic of a number of analyst reports. HC Wainwright upped their target price on shares of Myomo from $7.50 to $9.50 and gave the stock a “buy” rating in a report on Wednesday, March 12th. Alliance Global Partners reiterated a “buy” rating on shares of Myomo in a research note on Tuesday, March 11th. Craig Hallum increased their price objective on shares of Myomo from $9.00 to $11.00 and gave the company a “buy” rating in a research note on Tuesday, March 11th. Finally, Ascendiant Capital Markets increased their price objective on shares of Myomo from $9.00 to $11.00 and gave the company a “buy” rating in a research note on Monday, March 17th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $9.75.

Myomo Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.